Influence of serum cholesterol level and statin treatment on prostate cancer aggressiveness.

Influence of serum cholesterol level and statin treatment on prostate cancer aggressiveness.
复制标题

血清胆固醇水平和他汀类药物治疗对前列腺癌侵袭性的影响。

DOI:
10.18632/oncotarget.16943
复制
发表时间:
2017-07-18
期刊:
影响因子:
--
通讯作者:
Steinestel J
Steinestel J
中科院分区:
其他
文献类型:
--
作者:
Schnoeller TJ;Jentzmik F;Schrader AJ;Steinestel J

文献摘要

参考文献

被引文献

相似文献

胆固醇水平和他汀类药物的使用都影响前列腺癌(PC)的发展和预后。在本回顾性横断分析三级转诊中心连续病例中,我们评估了767例组织学证实、临床局限性PC等待根治性前列腺切除术的高胆固醇血症(≥5.0mmol/l)、他汀类药物的使用和晚期/侵袭性PC之间的关系。我们发现HCE患者(n=287, 37.4%)低分化PC (Gleason评分≥7b, 81.1% vs. 4.9%)、局部肿瘤分期晚期(≥pT3, 57.7% vs. 22.2%)和淋巴结累及(19.8% vs. 1.6%)的发生率显著升高。多因素logistic回归分析确定高胆固醇血症是侵袭性和/或晚期PC的危险因素(or 2.01, p<0.001),而他汀类药物摄入的优势比为0.49 (p=0.005),表明与高危PC呈负相关。尽管使用他汀类药物的患者数量有限(约9.5%),但经校正和加权的多因素logistic回归模型显示,术前高胆固醇血症与高危PC的诊断相关,而高危PC的诊断与他汀类药物的摄入有负相关。
Both cholesterol levels and the use of statins have been described to influence the development and prognosis of prostate cancer (PC). In this retrospective, cross-sectional analysis of consecutive cases from a tertiary referral center we evaluated an association between hypercholesterolemia (≥5.0mmol/l), the use of statins, and advanced/aggressive PC in 767 men with histologically confirmed, clinically localized PC awaiting radical prostatectomy. We found that patients with HCE (n=287, 37.4%) had a significantly higher incidence of poorly differentiated PC (Gleason score ≥7b, 81.1% vs. 4.9%), advanced local tumor stage (≥pT3, 57.7% vs. 22.2%), and nodal involvement (19.8% vs. 1.6%). Multivariate logistic regression analysis identified hypercholesterolemia as a risk factor for aggressive and/or advanced PC (OR 2.01, p<0.001) whereas statin intake showed an odds ratio of 0.49 (p=0.005) indicating a negative association with high-risk PC. Despite a limited number of patients using statins (~9.5%), adjusted and weighed multivariate logistic regression models revealed that preoperative hypercholesterolemia is associated with a diagnosis of high-risk PC which is negatively influenced by statin intake.
DOI: 10.1016/j.coph.2012.07.006
发表时间: 2012-12
影响因子: 4
作者:
Pelton, Kristine;Freeman, Michael R.;Solomon, Keith R.
通讯作者: Solomon, Keith R.
DOI: 10.1007/s10552-010-9691-6
发表时间: 2011-02
影响因子: 2.3
作者:
Batty, G. David;Kivimaeki, Mika;Clarke, Robert;Smith, George Davey;Shipley, Martin J.
通讯作者: Shipley, Martin J.
DOI: 10.1371/journal.pone.0046691
发表时间: 2012
期刊: PloS one
影响因子: 3.7
作者:
Bansal D;Undela K;D'Cruz S;Schifano F
通讯作者: Schifano F
DOI: 10.1200/jco.2010.31.5200
发表时间: 2011-04-20
影响因子: 45.3
作者:
Kitahara, Cari M.;de Gonzalez, Amy Berrington;Samet, Jonathan M.
通讯作者: Samet, Jonathan M.
DOI: 10.1093/jnci/djj499
发表时间: 2006-12-20
影响因子: 10.3
作者:
Platz, Elizabeth A.;Leitzmann, Michael F.;Giovannucci, Edward
通讯作者: Giovannucci, Edward